
Novavax signs COVID-19 license deal with Sanofi, removes doubt about business viability
Novavax signs COVID-19 license deal with Sanofi, removes doubt about business viability PARIS (Reute...
10th May, 2024

Novavax signs COVID-19 license deal with Sanofi, removes doubt about business viability PARIS (Reute...
10th May, 2024

People with two copies of a risk gene have genetic form of Alzheimer’s, scientists say By Julie Stee...
7th May, 2024

Smiling King Charles visits cancer centre on his return to public duties LONDON (Reuters) -A smiling...
30th April, 2024

Two million Britons suffer long COVID symptoms, survey shows By David Milliken LONDON (Reuters) – Tw...
25th April, 2024

Pfizer RSV shot meets goals in trial of high-risk adults under age 60 By Michael Erman (Reuters) – P...
9th April, 2024

Novo says Ozempic starter kits still not available in Germany in Q2 By Ludwig Burger FRANKFURT (Reut...
3rd April, 2024

King Charles doing ‘very well’, Camilla tells Belfast crowds LONDON (Reuters) – Britain’s Queen Cami...
21st March, 2024

AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase By Yadarisa Shabong...
19th March, 2024

UK royal Kate shown in first video since surgery, Sun says LONDON (Reuters) – Kate, Britain’s Prince...
19th March, 2024

AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers (Reuters) – Drugmak...
18th March, 2024

Wearable Medical Devices Market to hit $ 168.3 billion by 2030: Verified Market Research The Global...
6th March, 2024

Active Pharmaceutical Ingredients Market to hit $ 372.6 billion by 2030: Verified Market Reports The...
5th March, 2024